In T2DM-NAFLD subjects, authors found increased levels of Fatty acid-binding protein 1 (FABP1), a protein that facilitates the storage of FFAs and urges liver damage [79, 80]. This evidence concerns the gene FABP1 and metabolic dysfunction-associated steatotic liver disease.